APO Research
Talk to an analyst

APO RESEARCH · REPORT

TROP2-ADC Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global TROP2-ADC Drug Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchTROP2-ADC Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal TROP2-ADC Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal TROP2-ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TROP2-ADC Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal TROP2-ADC Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global TROP2-ADC Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the TROP2-ADC Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the TROP2-ADC Drug market include AstraZeneca, BiOneCure Therapeutics, Chiome Bioscience, Gilead, LegoChem Biosciences, Merck, Duoxi Biotech, Kelun Biotech and Shijian Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global TROP2-ADC Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of TROP2-ADC Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents TROP2-ADC Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the TROP2-ADC Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

TROP2-ADC Drug Segment by Company

AstraZeneca

BiOneCure Therapeutics

Chiome Bioscience

Gilead

LegoChem Biosciences

Merck

Duoxi Biotech

Kelun Biotech

Shijian Biotech

DualityBio

TROP2-ADC Drug Segment by Type

Clinical Drugs

Marketed Drugs

TROP2-ADC Drug Segment by Application

Hematological Tumors

Solid Tumors

TROP2-ADC Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global TROP2-ADC Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions TROP2-ADC Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify TROP2-ADC Drug significant trends, drivers, influence factors in global and regions.

6. To analyze TROP2-ADC Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TROP2-ADC Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TROP2-ADC Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TROP2-ADC Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the TROP2-ADC Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global TROP2-ADC Drug industry.

Chapter 3: Detailed analysis of TROP2-ADC Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of TROP2-ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of TROP2-ADC Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. TROP2-ADC Drug Industry Trends Table 2. TROP2-ADC Drug Industry Drivers Table 3. TROP2-ADC Drug Industry Opportunities and Challenges Table 4. TROP2-ADC Drug Industry Restraints Table 5. Global TROP2-ADC Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global TROP2-ADC Drug Revenue Share by Company (2021-2026) Table 7. Global TROP2-ADC Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global TROP2-ADC Drug Sales Volume Share by Company (2021-2026) Table 9. Global TROP2-ADC Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global TROP2-ADC Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global TROP2-ADC Drug Key Company Manufacturing Base & Headquarters Table 12. Global TROP2-ADC Drug Company, Product Type & Application Table 13. Global TROP2-ADC Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global TROP2-ADC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Clinical Drugs Table 18. Significant Companies of Marketed Drugs Table 19. Global TROP2-ADC Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global TROP2-ADC Drug Sales Volume by Type (2021-2026) & (K Units) Table 21. Global TROP2-ADC Drug Sales Volume by Type (2027-2032) & (K Units) Table 22. Global TROP2-ADC Drug Sales Volume Share by Type (2021-2026) Table 23. Global TROP2-ADC Drug Sales Volume Share by Type (2027-2032) Table 24. Global TROP2-ADC Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global TROP2-ADC Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global TROP2-ADC Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global TROP2-ADC Drug Sales Value Share by Type (2021-2026) Table 28. Global TROP2-ADC Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hematological Tumors Table 30. Significant Companies of Solid Tumors Table 31. Global TROP2-ADC Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global TROP2-ADC Drug Sales Volume by Application (2021-2026) & (K Units) Table 33. Global TROP2-ADC Drug Sales Volume by Application (2027-2032) & (K Units) Table 34. Global TROP2-ADC Drug Sales Volume Share by Application (2021-2026) Table 35. Global TROP2-ADC Drug Sales Volume Share by Application (2027-2032) Table 36. Global TROP2-ADC Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global TROP2-ADC Drug Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global TROP2-ADC Drug Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global TROP2-ADC Drug Sales Value Share by Application (2021-2026) Table 40. Global TROP2-ADC Drug Sales Value Share by Application (2027-2032) Table 41. Global TROP2-ADC Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global TROP2-ADC Drug Sales by Region (2021-2026) & (K Units) Table 43. Global TROP2-ADC Drug Sales Market Share by Region (2021-2026) Table 44. Global TROP2-ADC Drug Sales by Region (2027-2032) & (K Units) Table 45. Global TROP2-ADC Drug Sales Market Share by Region (2027-2032) Table 46. Global TROP2-ADC Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global TROP2-ADC Drug Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global TROP2-ADC Drug Sales Value Share by Region (2021-2026) Table 49. Global TROP2-ADC Drug Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global TROP2-ADC Drug Sales Value Share by Region (2027-2032) Table 51. Global TROP2-ADC Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global TROP2-ADC Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global TROP2-ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global TROP2-ADC Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 56. Global TROP2-ADC Drug Sales Market Share by Country (2021-2026) Table 57. Global TROP2-ADC Drug Sales by Country (2027-2032) & (K Units) Table 58. Global TROP2-ADC Drug Sales Market Share by Country (2027-2032) Table 59. Global TROP2-ADC Drug Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global TROP2-ADC Drug Sales Value Market Share by Country (2021-2026) Table 61. Global TROP2-ADC Drug Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global TROP2-ADC Drug Sales Value Market Share by Country (2027-2032) Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. AstraZeneca TROP2-ADC Drug Product Portfolio Table 67. AstraZeneca Recent Development Table 68. BiOneCure Therapeutics Company Information Table 69. BiOneCure Therapeutics Business Overview Table 70. BiOneCure Therapeutics TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. BiOneCure Therapeutics TROP2-ADC Drug Product Portfolio Table 72. BiOneCure Therapeutics Recent Development Table 73. Chiome Bioscience Company Information Table 74. Chiome Bioscience Business Overview Table 75. Chiome Bioscience TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chiome Bioscience TROP2-ADC Drug Product Portfolio Table 77. Chiome Bioscience Recent Development Table 78. Gilead Company Information Table 79. Gilead Business Overview Table 80. Gilead TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Gilead TROP2-ADC Drug Product Portfolio Table 82. Gilead Recent Development Table 83. LegoChem Biosciences Company Information Table 84. LegoChem Biosciences Business Overview Table 85. LegoChem Biosciences TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. LegoChem Biosciences TROP2-ADC Drug Product Portfolio Table 87. LegoChem Biosciences Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Merck TROP2-ADC Drug Product Portfolio Table 92. Merck Recent Development Table 93. Duoxi Biotech Company Information Table 94. Duoxi Biotech Business Overview Table 95. Duoxi Biotech TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Duoxi Biotech TROP2-ADC Drug Product Portfolio Table 97. Duoxi Biotech Recent Development Table 98. Kelun Biotech Company Information Table 99. Kelun Biotech Business Overview Table 100. Kelun Biotech TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Kelun Biotech TROP2-ADC Drug Product Portfolio Table 102. Kelun Biotech Recent Development Table 103. Shijian Biotech Company Information Table 104. Shijian Biotech Business Overview Table 105. Shijian Biotech TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Shijian Biotech TROP2-ADC Drug Product Portfolio Table 107. Shijian Biotech Recent Development Table 108. DualityBio Company Information Table 109. DualityBio Business Overview Table 110. DualityBio TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. DualityBio TROP2-ADC Drug Product Portfolio Table 112. DualityBio Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. TROP2-ADC Drug Distributors List Table 116. TROP2-ADC Drug Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. TROP2-ADC Drug Product Image Figure 2. Global TROP2-ADC Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TROP2-ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global TROP2-ADC Drug Sales (2021-2032) & (K Units) Figure 5. Global TROP2-ADC Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global TROP2-ADC Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Clinical Drugs Image Figure 10. Marketed Drugs Image Figure 11. Global TROP2-ADC Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global TROP2-ADC Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global TROP2-ADC Drug Sales Volume Share by Type (2021-2032) Figure 14. Global TROP2-ADC Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global TROP2-ADC Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global TROP2-ADC Drug Sales Value Share by Type (2021-2032) Figure 17. Hematological Tumors Image Figure 18. Solid Tumors Image Figure 19. Global TROP2-ADC Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global TROP2-ADC Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global TROP2-ADC Drug Sales Volume Share by Application (2021-2032) Figure 22. Global TROP2-ADC Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global TROP2-ADC Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global TROP2-ADC Drug Sales Value Share by Application (2021-2032) Figure 25. Global TROP2-ADC Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global TROP2-ADC Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global TROP2-ADC Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global TROP2-ADC Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America TROP2-ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 30. North America TROP2-ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe TROP2-ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 32. Europe TROP2-ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific TROP2-ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific TROP2-ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America TROP2-ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 36. South America TROP2-ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa TROP2-ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa TROP2-ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt TROP2-ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. TROP2-ADC Drug Value Chain Figure 124. Manufacturing Cost Structure Figure 125. TROP2-ADC Drug Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Drugs
  • Marketed Drugs
Applications
  • Hematological Tumors
  • Solid Tumors
Companies covered
  • AstraZeneca
  • BiOneCure Therapeutics
  • Chiome Bioscience
  • Gilead
  • LegoChem Biosciences
  • Merck
  • Duoxi Biotech
  • Kelun Biotech
  • Shijian Biotech
  • DualityBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global TROP2-ADC Drug Sales Value (2021-2032)
  4. 1.2.2 Global TROP2-ADC Drug Sales Volume (2021-2032)
  5. 1.2.3 Global TROP2-ADC Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 TROP2-ADC Drug Market Dynamics
  1. 2.1 TROP2-ADC Drug Industry Trends
  2. 2.2 TROP2-ADC Drug Industry Drivers
  3. 2.3 TROP2-ADC Drug Industry Opportunities and Challenges
  4. 2.4 TROP2-ADC Drug Industry Restraints
3 TROP2-ADC Drug Market by Company
  1. 3.1 Global TROP2-ADC Drug Company Revenue Ranking in 2025
  2. 3.2 Global TROP2-ADC Drug Revenue by Company (2021-2026)
  3. 3.3 Global TROP2-ADC Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global TROP2-ADC Drug Average Price by Company (2021-2026)
  5. 3.5 Global TROP2-ADC Drug Company Ranking (2024-2026)
  6. 3.6 Global TROP2-ADC Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global TROP2-ADC Drug Company Product Type and Application
  8. 3.8 Global TROP2-ADC Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global TROP2-ADC Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 TROP2-ADC Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 TROP2-ADC Drug Market by Type
  1. 4.1 TROP2-ADC Drug Type Introduction
  2. 4.1.1 Clinical Drugs
  3. 4.1.2 Marketed Drugs
  4. 4.2 Global TROP2-ADC Drug Sales Volume by Type
  5. 4.2.1 Global TROP2-ADC Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global TROP2-ADC Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global TROP2-ADC Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global TROP2-ADC Drug Sales Value by Type
  9. 4.3.1 Global TROP2-ADC Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global TROP2-ADC Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global TROP2-ADC Drug Sales Value Share by Type (2021-2032)
5 TROP2-ADC Drug Market by Application
  1. 5.1 TROP2-ADC Drug Application Introduction
  2. 5.1.1 Hematological Tumors
  3. 5.1.2 Solid Tumors
  4. 5.2 Global TROP2-ADC Drug Sales Volume by Application
  5. 5.2.1 Global TROP2-ADC Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global TROP2-ADC Drug Sales Volume by Application (2021-2032)
  7. 5.2.3 Global TROP2-ADC Drug Sales Volume Share by Application (2021-2032)
  8. 5.3 Global TROP2-ADC Drug Sales Value by Application
  9. 5.3.1 Global TROP2-ADC Drug Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global TROP2-ADC Drug Sales Value by Application (2021-2032)
  11. 5.3.3 Global TROP2-ADC Drug Sales Value Share by Application (2021-2032)
6 TROP2-ADC Drug Regional Sales and Value Analysis
  1. 6.1 Global TROP2-ADC Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global TROP2-ADC Drug Sales by Region (2021-2032)
  3. 6.2.1 Global TROP2-ADC Drug Sales by Region: 2021-2026
  4. 6.2.2 Global TROP2-ADC Drug Sales by Region (2027-2032)
  5. 6.3 Global TROP2-ADC Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global TROP2-ADC Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global TROP2-ADC Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global TROP2-ADC Drug Sales Value by Region (2027-2032)
  9. 6.5 Global TROP2-ADC Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America TROP2-ADC Drug Sales Value (2021-2032)
  12. 6.6.2 North America TROP2-ADC Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe TROP2-ADC Drug Sales Value (2021-2032)
  15. 6.7.2 Europe TROP2-ADC Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific TROP2-ADC Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific TROP2-ADC Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America TROP2-ADC Drug Sales Value (2021-2032)
  21. 6.9.2 South America TROP2-ADC Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa TROP2-ADC Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa TROP2-ADC Drug Sales Value Share by Country, 2025 VS 2032
7 TROP2-ADC Drug Country-level Sales and Value Analysis
  1. 7.1 Global TROP2-ADC Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global TROP2-ADC Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global TROP2-ADC Drug Sales by Country (2021-2032)
  4. 7.3.1 Global TROP2-ADC Drug Sales by Country (2021-2026)
  5. 7.3.2 Global TROP2-ADC Drug Sales by Country (2027-2032)
  6. 7.4 Global TROP2-ADC Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global TROP2-ADC Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global TROP2-ADC Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt TROP2-ADC Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt TROP2-ADC Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt TROP2-ADC Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca TROP2-ADC Drug Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 BiOneCure Therapeutics
  8. 8.2.1 BiOneCure Therapeutics Company Information
  9. 8.2.2 BiOneCure Therapeutics Business Overview
  10. 8.2.3 BiOneCure Therapeutics TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BiOneCure Therapeutics TROP2-ADC Drug Product Portfolio
  12. 8.2.5 BiOneCure Therapeutics Recent Developments
  13. 8.3 Chiome Bioscience
  14. 8.3.1 Chiome Bioscience Company Information
  15. 8.3.2 Chiome Bioscience Business Overview
  16. 8.3.3 Chiome Bioscience TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chiome Bioscience TROP2-ADC Drug Product Portfolio
  18. 8.3.5 Chiome Bioscience Recent Developments
  19. 8.4 Gilead
  20. 8.4.1 Gilead Company Information
  21. 8.4.2 Gilead Business Overview
  22. 8.4.3 Gilead TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Gilead TROP2-ADC Drug Product Portfolio
  24. 8.4.5 Gilead Recent Developments
  25. 8.5 LegoChem Biosciences
  26. 8.5.1 LegoChem Biosciences Company Information
  27. 8.5.2 LegoChem Biosciences Business Overview
  28. 8.5.3 LegoChem Biosciences TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 LegoChem Biosciences TROP2-ADC Drug Product Portfolio
  30. 8.5.5 LegoChem Biosciences Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck TROP2-ADC Drug Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Duoxi Biotech
  38. 8.7.1 Duoxi Biotech Company Information
  39. 8.7.2 Duoxi Biotech Business Overview
  40. 8.7.3 Duoxi Biotech TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Duoxi Biotech TROP2-ADC Drug Product Portfolio
  42. 8.7.5 Duoxi Biotech Recent Developments
  43. 8.8 Kelun Biotech
  44. 8.8.1 Kelun Biotech Company Information
  45. 8.8.2 Kelun Biotech Business Overview
  46. 8.8.3 Kelun Biotech TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kelun Biotech TROP2-ADC Drug Product Portfolio
  48. 8.8.5 Kelun Biotech Recent Developments
  49. 8.9 Shijian Biotech
  50. 8.9.1 Shijian Biotech Company Information
  51. 8.9.2 Shijian Biotech Business Overview
  52. 8.9.3 Shijian Biotech TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shijian Biotech TROP2-ADC Drug Product Portfolio
  54. 8.9.5 Shijian Biotech Recent Developments
  55. 8.10 DualityBio
  56. 8.10.1 DualityBio Company Information
  57. 8.10.2 DualityBio Business Overview
  58. 8.10.3 DualityBio TROP2-ADC Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 DualityBio TROP2-ADC Drug Product Portfolio
  60. 8.10.5 DualityBio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 TROP2-ADC Drug Value Chain Analysis
  2. 9.1.1 TROP2-ADC Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 TROP2-ADC Drug Sales Mode & Process
  6. 9.2 TROP2-ADC Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 TROP2-ADC Drug Distributors
  9. 9.2.3 TROP2-ADC Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst